4LB5 affects cancer cell survival. Indicated panels were treated with increasing amount of 4LB5: (A) T47D, (B) BT-549, (C) MDA-MB-436, (D) PLC-PRF, (E) Huh7; (F) MCF-10a. Viable cells were counted using trypan blue staining at different time points (24, 48, and 72 h). All of the experiments are representative of three independent experiments performed in quadruplicate. Mean ± SD is reported. ***P < 0.001.